Efficacy of Platelet Enriched Plasma in Preventing Surgery for Patients With Chronic Tympanic Membrane Perforation
Phase 1
Terminated
- Conditions
- Tympanic Membrane Perforation
- Interventions
- Biological: Platelet Rich Plasma
- Registration Number
- NCT03837665
- Lead Sponsor
- University of Kansas Medical Center
- Brief Summary
By doing this study, researchers hope to find out if platelet rich plasma (PRP) can heal holes in the eardrum as an alternative to surgery.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 1
Inclusion Criteria
- Patients who meet criteria for tympanoplasty procedure
- Willing to comply with the protocol and attend all study visits
- Able to provide written informed consent
Exclusion Criteria
- Patients who have previously undergone middle ear or lateral skull base surgery
- Patients who would not qualify for a tympanoplasty
- Any type of platelet disorder, cancer, or ongoing systemic infection
- Any type of hemodynamic instability, septicemia, infection, tobacco use, any use of steroids to the ear drums
- Type I diabetes or other autoimmune pathology
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description PRP Treatment Platelet Rich Plasma Participants receive platelet rich plasma treatment. Participants will be asked to make up to 5 trips to the clinic (one for eligibility, one for the PRP, three follow-up visits). Participation is expected to last up to about 6 weeks. After the second visit and application of PRP, patients will be monitored closely for any complications or concerns. This will include a follow up phone call 3-5 days after the initial application of PRP. Patients will also be followed closely in 2 week intervals or sooner should any problems or concerns arise.
- Primary Outcome Measures
Name Time Method Prevention of Patients Requiring Surgery 6 Weeks Number of participants that are able to avoid surgery for their perforation.
- Secondary Outcome Measures
Name Time Method Time to Healing 6 Weeks Size of perforation
Trial Locations
- Locations (1)
University of Kansas Medical Center
🇺🇸Kansas City, Kansas, United States